Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer

NCT02817113 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped Strategy change

Conditions

Head and Neck Neoplasms

Interventions

DRUG: NC-6004
DRUG: Cetuximab
DRUG: 5-FU

Sponsor

Orient Europharma Co., Ltd.

Collaborators

[object Object]